MECLITAB Meclizine Tablet 12.5 mg
________________________________________
DESCRIPTION
MECLITAB Meclizine Tablet 12.5 mg contains meclizine hydrochloride, an antihistamine with anti emetic and antivertigo properties. It works by reducing stimulation of the vestibular system and suppressing nausea and vomiting associated with balance disorders and motion sickness.
________________________________________
USES
• Prevention and treatment of motion sickness
• Management of vertigo associated with vestibular disorders
• Relief of nausea, vomiting, and dizziness related to inner ear conditions
• Symptomatic treatment of balance disturbances, as prescribed
________________________________________
DOSAGE
• Motion sickness (Adults): 12.5–25 mg taken 1 hour before travel; may be repeated every 24 hours if required
• Vertigo: 12.5–25 mg taken 2–3 times daily, as directed by a healthcare professional
Note: Dosage and duration depend on the condition and patient response. Follow the physician’s instructions strictly.
________________________________________
PRECAUTIONS
• May cause drowsiness; avoid driving or operating machinery if affected
• Use with caution in patients with glaucoma, enlarged prostate, or urinary retention
• Avoid alcohol and other sedatives, as they may increase drowsiness
• Use with caution in elderly patients due to increased sensitivity to side effects
• Pregnancy and breastfeeding: use only if prescribed by a healthcare professional
• Inform the doctor of all other medications being taken
________________________________________
SIDE EFFECTS
• Drowsiness or sedation
• Dry mouth
• Blurred vision
• Headache
• Fatigue
• Rarely, confusion (especially in elderly patients)
Consult a healthcare professional if side effects persist or worsen.
________________________________________
STORAGE
• Store below 30 °C
• Keep in a dry place, protected from light and moisture
• Keep out of reach of children